SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Joe DePinto was elected to Target's Board of Directors effective August 1, 2026, and appointed to the Audit & Risk Committee and Infrastructure & Finance Committee. This is a clear executive appointment of a director with significant retail and operational expertise (former 7-Eleven CEO). Board appointments of experienced executives are material to investors as they affect governance and strategic direction.
View raw filing on EDGAR →Edric C. Funk was elected President and Chief Executive Officer effective November 1, 2026, and immediately appointed to the Board of Directors. Richard M. Olson, the outgoing CEO, transitions to Executive Chairman. The filing also addresses compensation adjustments for both executives as part of this planned succession.
View raw filing on EDGAR →The filing discloses the appointment of Brent Stuart as Chief Executive Officer effective January 1, 2027, and his election to the Board effective July 22, 2026. While Rick Wessel's transition to Executive Chairman represents a departure from the CEO role, the principal disclosed action centers on Stuart's appointment to the CEO position and Board membership. This is a material executive succession event affecting the registrant's leadership structure.
View raw filing on EDGAR →The 6-K discloses the Board of Directors' appointment of Manuel García Diez as Chief Financial Officer (CFO) of Telecom Argentina, effective August 3, 2026. This is a clear executive appointment of a named officer to a material C-suite position. CFO appointments are material to investors as they affect financial oversight and governance.
View raw filing on EDGAR →Don W. Cummings was appointed Chief Executive Officer, President, and director effective October 1, 2026, with a compensation package of $1,050,000 base salary and $7,850,000 in long-term incentives. Brian M. Walta was simultaneously appointed Executive Vice President and Chief Financial Officer effective the same date with $600,000 base salary and $1,900,000 in long-term incentives. These appointments represent a material succession event affecting the company's top leadership.
View raw filing on EDGAR →Jennifer M. Grigsby was elected to the Board of Directors on July 21, 2026, filling the vacancy created by Stephen Lee's resignation. Grigsby, a veteran public company director and energy finance executive with over 30 years of leadership experience, was appointed to serve as Chair of the Compensation Committee and member of the Nominating & Governance and Audit Committees.
View raw filing on EDGAR →David C. Dennsteadt was named President and Chief Operating Officer effective July 17, 2026, with expanded responsibilities overseeing operating groups and leadership of strategy and corporate development.
View raw filing on EDGAR →Jeffrey Hanson appointed as permanent CEO (effective July 21, 2026) after serving as Interim CEO since February 2026; Gabe Willhite promoted to President and COO; and Scott Estes appointed Lead Independent Director. Danny Prosky retired from his CEO role as part of this leadership succession.
View raw filing on EDGAR →Joseph Risico was appointed as a director to fill an existing Class I vacancy, and Ryan Daiss was appointed as President with detailed employment terms including base salary, performance bonuses, equity awards, and severance provisions.
View raw filing on EDGAR →The 6-K discloses the appointment of Yu Guo as an independent director and chair of the audit committee on July 20, 2026, following the resignation of Jiahe Liao. While both a departure and appointment occur, the principal disclosed action is the appointment of a new director to fill the vacancy, making exec_appointment the primary classification. The appointment is material because it involves a change in board composition and audit committee leadership at a Nasdaq-listed company.
View raw filing on EDGAR →The filing discloses both the resignation of CFO Polly Schneck and the appointment of John Boone as her successor, effective July 22, 2026. While both events occur, the disclosure centers substantively on Boone's appointment—his background, experience, and qualifications receive detailed treatment, whereas Schneck's departure is noted briefly as non-contentious. The appointment of a new CFO is material to investors assessing the company's financial leadership and operational continuity, particularly for a SPAC (NewHold Investment Corp IV) navigating post-IPO operations.
View raw filing on EDGAR →Susan Hunt was appointed as Chief Revenue Officer, effective July 17, 2026, to lead the Company's global revenue strategy and sales organization. Dr. Pouya Dianat transitioned from CRO to the newly created Chief Product Officer role.
View raw filing on EDGAR →Matthew Kreps was appointed to the Board of Directors of ASTROTECH Corp on July 16, 2026, increasing the board size from six to seven directors. Kreps brings extensive background in capital markets and investor relations, and received a restricted stock grant of 2,150 shares as part of his appointment.
View raw filing on EDGAR →AXT appointed Jia-Bin Duh as a Class III independent director effective July 16, 2026, expanding the Board from five to six members. Duh brings 30+ years of senior executive leadership at major technology companies (Hewlett-Packard, Microsoft, Cisco) and deep expertise in Greater China markets to support the company's subsidiary Tongmei and long-term growth strategy.
View raw filing on EDGAR →The filing discloses the appointment of Anuj Goel as Chief Financial Officer of SharonAI Holdings Inc., effective August 24, 2026. While the press release also mentions the departure of incumbent CFO Tim Broadfoot, the principal disclosed action centers on the appointment of a named executive to a C-suite officer role. The appointment is material as it affects the company's executive leadership during a growth phase.
View raw filing on EDGAR →The filing discloses the appointment of Alexander Asgary as Chief Strategy Officer effective July 16, 2026, along with a concurrent consulting agreement providing $250,000 annual compensation plus $250,000 in warrant awards. While the filing also mentions Chris Chumas's transition to EVP of a subsidiary, the principal disclosed action centers on Asgary's appointment to a C-suite role with material compensation terms, making this an executive appointment event.
View raw filing on EDGAR →The filing discloses the appointment of Mort Aaronson as a member of the Board of Directors on July 1, 2026, to fill a vacancy. The principal disclosed action is a person taking a role (board director), supported by detailed biographical information and the execution of a Director Agreement and Indemnification Agreement with specified compensation ($75,000 annually in shares). This is a clear executive appointment event.
View raw filing on EDGAR →The Board appointed Dr. Alexander Vollert as a director effective August 1, 2026. This is a clear executive appointment to the Board of Directors. While the disclosure notes that Guidewire recognized $11.3 million and $13.4 million in revenue from AXA SA (Dr. Vollert's former employer) during the relevant periods, the principal disclosed action is the appointment of a new director with significant operational and CEO experience at a major insurance company, which is material to investors assessing board composition and governance.
View raw filing on EDGAR →The exhibit discloses the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, effective July 22, 2026, with induction into the Management Council. This is a senior executive appointment that would materially affect investor assessment of the company's leadership and strategic direction in its biologics division. The secondary disclosure of the auditor appointment (Deloitte Haskins & Sells, LLP) is a routine auditor change that does not override the primary event.
View raw filing on EDGAR →The Board approved on July 22, 2026, the appointment of Dr. Sridevi Khambhampaty as Global Head of Biologics and Senior Management Personnel, with induction into the Management Council.
View raw filing on EDGAR →The filing discloses two executive transitions: Keith Regnante's resignation as CFO effective August 3, 2026, and Annita Tanini's appointment as interim principal financial officer and principal accounting officer effective August 4, 2026. While both events occur, the principal disclosed action centers on Tanini's appointment to the CFO role, including detailed compensation arrangements ($302,300 base salary, 30% bonus target, severance terms). The filing emphasizes her qualifications and new employment agreement, making the appointment the salient event, though Regnante's departure is also disclosed.
View raw filing on EDGAR →The filing discloses the appointment of three new directors—Gemma Hemsworth, Fiona Callering, and Alistair Pemberton—to the Board of Directors of OXO, Inc., effective immediately on July 22, 2026. This is a clear executive appointment event under Item 5.02, as the principal disclosed action is persons taking board roles. Board composition changes are material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →The filing discloses the appointment of Farrell Simon, Pharm.D., to Serina's Board of Directors effective July 22, 2026, with concurrent appointment to the Audit and Compensation Committees. Dr. Simon brings significant commercial and business development expertise from his role as Chief Commercial Officer at Trevi Therapeutics and prior decade at Pfizer, making this a material governance event affecting board composition and oversight capabilities at a clinical-stage biotech company.
View raw filing on EDGAR →The Board of Directors approved the appointment of Mark Jones, Jr., the Company's President and Chief Operating Officer, as CEO effective January 1, 2027, to succeed retiring CEO Mark Miller.
View raw filing on EDGAR →The Board of Directors elected two new directors, David S. Marriott and Charles J. Meyers, effective July 20, 2026, and appointed them to specific board committees. This is a clear executive appointment event. While the disclosure also mentions standard non-employee director compensation, the principal action disclosed is the appointment of these two individuals to the Board, making this a material governance event affecting the composition of the company's leadership.
View raw filing on EDGAR →The filing discloses the election of Octavio Marquez, president and CEO of Diebold Nixdorf, to MSA Safety's Board of Directors on July 20, 2026. This is a clear appointment of a director to the company's board, which is material to investors as board composition affects governance and strategic oversight. The disclosure explicitly states "the Board of Directors of MSA Safety Incorporated elected Octavio Marquez to the Company's Board of Directors" and notes his appointment was part of the board's regular succession plans.
View raw filing on EDGAR →The filing discloses the election of David S. Schulz to Fulton Financial Corporation's board of directors, effective September 14, 2026, with appointment to the Audit and Risk committees. While the disclosure includes compensatory arrangements (pro rata RSU grant of $64,400), the principal disclosed action is the appointment of a director to the board. Schulz brings significant financial leadership experience from Wesco International and Armstrong World Industries, making this a material governance event affecting board composition and expertise.
View raw filing on EDGAR →Bina Mehta was elected as an independent director of ExlService Holdings, effective July 16, 2026, with concurrent appointments to the Audit Committee and Compensation and Talent Management Committee.
View raw filing on EDGAR →The 6-K discloses the appointment of Mr. Hung-Hsien Yen to the Board of Directors effective July 20, 2026, along with his committee assignments (Audit Committee member and Nominating and Corporate Governance Committee Chairman) and compensation terms. Although two directors also resigned on the same date, the principal disclosed action is the appointment of a new director with specified governance roles and equity/cash compensation arrangements, which is the hallmark of exec_appointment under Item 5.02.
View raw filing on EDGAR →James Beecham was appointed as a Class I Director to Aware Inc's Board of Directors on July 15, 2026, upon recommendation of the Nominating and Corporate Governance Committee.
View raw filing on EDGAR →Jonathan E. Benfield was appointed Chief Financial Officer of CrossAmerica GP LLC, the general partner, effective immediately on July 20, 2026, transitioning from his interim role since March 2, 2026.
View raw filing on EDGAR →Constantine Dakolias was appointed as a director and audit committee member of Bleichroeder Acquisition Corp. III effective July 20, 2026. The disclosure centers on the appointment of a qualified independent director with extensive investment and credit management experience, making this a clear executive appointment event material to investors evaluating the company's governance and board composition.
View raw filing on EDGAR →The filing discloses the Board's nomination of Mr. Ng Tsze Lun for election as a director and his appointment as Chairman of the Board effective after stockholder approval at the 2026 annual meeting. While the filing also mentions Mr. Choi Lin Hung's decision not to stand for re-election as director and Chairman, the principal disclosed action centers on the appointment of Mr. Ng to the Chairman role. The press release reinforces this as a "Board Leadership Transition" with Mr. Ng succeeding Mr. Choi as Chairman, making the appointment the salient event.
View raw filing on EDGAR →The 6-K discloses the appointment of Mr. Nazario Matachione as a member of the Board of Directors of RoyaLand Company, Ltd. effective July 16, 2026. The filing explicitly states "the Board of Directors of The RoyaLand Company, Ltd. (the "Company") appointed Mr. Nazario Matachione as a member of the Board" and provides extensive biographical detail on his qualifications and experience. This is a clear executive appointment to the board, material to investors assessing the company's governance and leadership.
View raw filing on EDGAR →Getty Images appointed two new independent directors—Elizabeth Abrams and Thomas Walper—to its Board of Directors effective July 20, 2026. Ms. Abrams was also appointed to the Audit Committee, and both directors entered into independent director agreements providing monthly fees of $50,000 plus additional compensation.
View raw filing on EDGAR →Three independent directors—Andrew Childs, Michael Westerman, and Karl Simich—were appointed to the board of AMR Resources Acquisition Corp. in connection with the IPO on July 16, 2026, with assignments to the Audit and Compensation Committees.
View raw filing on EDGAR →Phio Pharmaceuticals appointed R. Todd Plott, M.D. to its Board of Directors effective July 20, 2026, increasing the board size to six members. Dr. Plott brings 30+ years of dermatologic experience and prior FDA advisory committee service, directly relevant to the company's clinical-stage development of PH-762 for skin cancers.
View raw filing on EDGAR →Dennis C. Schemm was elected to Blink Charging's Board of Directors effective July 19, 2026. The filing discloses his extensive financial and executive background, including current CFO role at FOX Factory and prior CFO positions at Trex Company and Continental Building Products. Board appointments of experienced executives with relevant expertise are material governance events affecting the registrant's leadership composition.
View raw filing on EDGAR →The Board appointed Maen Razouqi as an additional independent director, effective August 1, 2026. This is a clear executive/director appointment disclosed under Item 5.02(d). While the disclosure also mentions standard director compensation arrangements, the principal action is the appointment of a new board member, making this an exec_appointment event.
View raw filing on EDGAR →The filing discloses the election of Michael Casey as a director and his appointment as chair of the Audit Committee, effective July 15, 2026. While the filing also mentions Michael McConnell's resignation as a director, the primary focus and substantive disclosure centers on Casey's appointment to the Board and his assumption of the Audit Committee chair role. The press release emphasizes Casey's qualifications and his return to the Board, making the appointment the salient event. Director and committee chair appointments are material governance changes affecting investor assessment of board composition and oversight.
View raw filing on EDGAR →Upland Software appointed Jennifer Simon as Chief Financial Officer, effective August 17, 2026. Simon brings over 20 years of finance leadership experience in software and private equity, including prior roles at NextGen Healthcare and Quest Software, and will oversee financial planning, accounting, treasury, tax, and investor relations reporting to the CEO.
View raw filing on EDGAR →The exhibit announces the appointment of Christophe Van de Weyer as Head of Business Area Global Communications Platform and CEO of Vonage, and his addition to Ericsson's Executive Team. While the disclosure also includes Niklas Heuveldop's departure effective August 15, 2026, the principal disclosed action is the appointment of Van de Weyer to a critical executive role. This is material as it affects leadership of a significant business unit and the composition of the Executive Team.
View raw filing on EDGAR →Michael B. Hollar was elected to the Boards of Directors of both Peoples Bancorp of North Carolina, Inc. and its subsidiary Peoples Bank on July 16, 2026.
View raw filing on EDGAR →The filing discloses the appointment of Minh Collins as both Chief Executive Officer and director of GBT Technologies, effective July 16, 2026, immediately following Patrick Bertagna's departure. While the section covers both a departure and an appointment, the principal disclosed action centers on Collins taking the CEO and board roles. The appointment of a new CEO is material to investors as it represents a change in leadership and control of the company.
View raw filing on EDGAR →The filing discloses the appointment of Brian Fisher as President of MediaCo Holding Inc., effective July 20, 2026, along with detailed compensation arrangements including a $450,000 base salary (escalating to $600,000), discretionary bonus up to 60-115% of base salary, and equity awards totaling approximately $1.94 million in restricted and performance stock units. This is a material executive appointment affecting the company's leadership structure.
View raw filing on EDGAR →The exhibit announces the appointment of two new directors to Frontier's Board: Joshua Girnun (Co-Founder and Managing Partner of Ridge Metals Group) and Donal Carroll (CFO of Quantum BioPharma Ltd., with 20+ years of corporate finance and public company experience). The press release explicitly states "The Board has appointed Joshua Girnun...and Donal Carroll...as new directors" and describes their qualifications and roles. While the exhibit also mentions departing directors and committee reconstitutions, the principal disclosed action is the appointment of these two new board members, making this an exec_appointment event. This is material as board composition changes affect governance and investor assessment of leadership quality.
View raw filing on EDGAR →Lightwave Logic appointed Fred A. Graffam III as Chief Financial Officer, effective immediately on July 20, 2026. Graffam brings over 20 years of financial leadership experience and prior CFO roles at Fidium, Ascent Capital Group, and DigitalGlobe. His compensation package includes a base salary of $450,000, a performance bonus up to 40%, a sign-on cash bonus of $70,000, and restricted stock units valued at $2,400,000.
View raw filing on EDGAR →The filing discloses the appointment of Kevin O'Connor as President of Hanover Bancorp, Inc. and Hanover Community Bank, effective July 27, 2026. While the disclosure includes compensatory details (base salary, incentive compensation eligibility, and a 10,000-share restricted stock award vesting over five years), the principal action and focus of Item 5.02(c) is the appointment itself. The compensation terms are incidental to the appointment announcement and do not constitute a standalone compensatory arrangement disclosure under Item 5.02(e).
View raw filing on EDGAR →The Board of Directors appointed Tara Bunch as a director on July 16, 2026. Ms. Bunch brings significant operational and governance experience from senior roles at Airbnb, Apple, and Hewlett-Packard, as well as board service at The Vanguard Group.
View raw filing on EDGAR →Enzo Villani, who was Executive Chairman and Chief Investment Officer, has been appointed to serve as President of Alpha Compute Corp, effective July 16, 2026. This is a material executive appointment expanding his role to include "broader responsibility for corporate strategy, capital allocation, and operational execution." The appointment of a senior executive to a new C-suite position is material to investors assessing company leadership and governance.
View raw filing on EDGAR →